[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17628-17629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05943]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1163]


Bulk Manufacturer of Controlled Substances Application: Sigma 
Aldrich Research Biochemicals, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Sigma Aldrich Research Biochemicals, Inc. has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
May 22, 2023. Such persons may also file a written request for a 
hearing on the application on or before May 22, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal,

[[Page 17629]]

which provides the ability to type short comments directly into the 
comment field on the web page or attach a file for lengthier comments. 
Please go to https://www.regulations.gov and follow the online 
instructions at that site for submitting comments. Upon submission of 
your comment, you will receive a Comment Tracking Number. Please be 
aware that submitted comments are not instantaneously available for 
public view on https://www.regulations.gov. If you have received a 
Comment Tracking Number, your comment has been successfully submitted 
and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 13, 2023, Sigma Aldrich Research Biochemical, 
Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to 
be registered as a bulk manufacturer of the following basic class(es) 
of controlled substance(s):

------------------------------------------------------------------------
            Controlled substance               Drug code     Schedule
------------------------------------------------------------------------
Cathinone...................................        1235  I
Mephedrone (4-Methyl-N-methylcathinone).....        1248  I
Methaqualone................................        2565  I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-       7118  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-                    7201  I
 naphthoyl)indole).
Lysergic acid diethylamide..................        7315  I
Tetrahydrocannabinols.......................        7370  I
Mescaline...................................        7381  I
2,5-Dimethoxyamphetamine....................        7396  I
3,4-Methylenedioxymethamphetamine...........        7405  I
Alpha-methyltryptamine......................        7432  I
Dimethyltryptamine..........................        7435  I
5-Methoxy-N,N-diisopropyltryptamine.........        7439  I
N-Benzylpiperazine..........................        7493  I
2C-H 2-(2,5-Dimethoxyphenyl)ethanamine).....        7517  I
MDPV (3,4-Methylenedioxypyrovalerone).......        7535  I
Methylone (3,4-Methylenedioxy-N-                    7540  I
 methylcathinone).
Heroin......................................        9200  I
Normorphine.................................        9313  I
Norlevorphanol..............................        9634  I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-         9821  I
 yl)-N-phenylacetamide).
Amphetamine.................................        1100  II
Methylphenidate.............................        1724  II
Nabilone....................................        7379  II
Phencyclidine...............................        7471  II
Cocaine.....................................        9041  II
Codeine.....................................        9050  II
Ecgonine....................................        9180  II
Levorphanol.................................        9220  II
Meperidine..................................        9230  II
Methadone...................................        9250  II
Morphine....................................        9300  II
Thebaine....................................        9333  II
Levo-alphacetylmethadol.....................        9648  II
Noroxymorphone..............................        9668  II
Remifentanil................................        9739  II
Sufentanil..................................        9740  II
Carfentanil.................................        9743  II
Tapentadol..................................        9780  II
Fentanyl....................................        9801  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
as reference standards. No other activities for these drug codes are 
authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-05943 Filed 3-22-23; 8:45 am]
BILLING CODE P